References
- Pert C. B., Snyder S. H. Properties of opiate-receptor binding in rat brain. Proc. Nat. Acad. Sci. USA. 1973; 70: 2243
- Chavkin C., Cox B. M., Goldstein A. Stereospecific opiate binding in bovine adrenal medulla. Mol. Pharmacol. 1979; 15: 751
- Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine-like drugs in the non dependent- and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976; 197: 517
- Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: Multiple agonists and receptors. Nature 1977; 267: 495
- Pfeiffer A., Herz A. Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047. Biochem. and Biophys. Res. Comm. 1981; 101: 38
- Zukin R. S., Zukin S. R. Multiple opiate receptors: emerging concepts. Life Sciences 1981; 29: 2681
- Wolozin B. L., Pasternak G. W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA. 1981; 78: 6181
- Leslie F. M., Chavkin C., Cox B. M. Opioid binding properties of brain and peripheral tissues: Evidence for heterogeneity in opioid ligand binding sites. J. Pharmacol. Exp. Ther. 1980; 214: 395
- Kumakura K., Karoum F., Guidotti A., Costa E. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells. Nature 1980; 283: 489
- Lemaire S., Livett B., Tseng R., Mercier P., Lemaire I. Studies on the inhibitory action of opiate compounds in isolated bovine adrenal chromaffin cells: Non-involvement of Stereospecific opiate binding sites. J. Neurcochem. 1981; 36: 886
- Kosterlitz H. W., Lord J. A.H., Paterson S. J., Waterfield A. A. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with δ and μ receptors. Br. J. Pharmacol. 1980; 68: 333
- Rigter H., Hannan T. J., Hessing R. B., Martinez J. L., Vasquez B. J., Jensen R. A., Veliquette J., McGaugh J. L. Enkephalins interfere with acquisition of an active avoidance response. Life Sciences 1980; 26: 337
- Chavkin C., James I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the opioid receptor. Science 1982; 215: 413
- Snyder S. H., Goodman R. R. Multiple neurotransmitter receptors. J. Neurochem. 1980; 35: 5
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265
- Simantov R., Snowman A. M., Snyder S. H. Temperature and ionic influences on opiate receptor binding. Mol. Pharmacol. 1976; 12: 977
- Chang K-J., Killian A., Hazum E., Cuatrecasas P., Chang J-K. Morphiceptin (NH4-TYR-PRO-PHE-PRO-CONH2): A potent and specific agonist for morphine (μ) receptors. Science 1981; 212: 75
- Dimaio J., Schiller P. W. A cyclic enkephalin analog with high in vitro opiate activity. Proc. Natl. Acad. Sci. USA. 1980; 77: 7162
- Fredrickson R. C., Smithwick E. L., Shuman R., Bemis K. G. Metkephamid, a systemically active analog of methionine enkephalin with potent opioid δ-receptor activity. Science 1981; 211: 603
- Gacel G., Fournie-Zaluski M-C., Roques B. P. D-TYR-SER-GLY-PHE-LEU-THR, a highly preferential ligand for δ-opiate receptors. FEBS Lett. 1980; 118: 245
- Shimohigashi Y., Costa T., Chen H C., Rodbard D. Dimeric tetrapeptide enkephalins display extraordinary selectivity for the opiate receptor. Nature 1982; 297: 333
- Wuster M., Schulz R., Herz A. Specificity of opioids towards the μ-, δ- and ε-opiate receptor. Neurosci. Lett. 1978; 15: 193
- Pasternak G. W. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia. Proc. Natl. Acad. Sci. USA. 1980; 77: 3691